跳至主要内容
临床试验/NL-OMON46744
NL-OMON46744已完成不适用

Self-Management And Telemedicine in patients with COPD and chronic Heart failure. - MATCH study

Medisch Spectrum Twente0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - A clinical diagnosis of COPD according to the GOLD 2017 criteria (Forced Expiratory Volume in one second (FEV1) < 80% of the predicted value and FEV1/Vital Capacity (FVC) < 0.70
  • - Chronic Heart Failure (CHF) defined according to the current (2016) ESC guidelines
  • - * 2 COPD and/or CHF exacerbations* and/or *1 hospitalisation for COPD and/or CHF in the two years preceding study entry
  • - * 40 years of age
  • - At least 1 week after prednisolone/antibiotics/furosemide course. At least 1 week after hospitalisation. At least 4 weeks post-rehabilitation.
  • - Able to understand and read the Dutch language
  • - Able to use a tablet
  • - Written informed consent from the subject prior to participation.

排除标准

  • - Terminal cancer or the end stage of another serious disease;
  • - Other serious lung disease (e.g. 1-antitrypsin deficiency; interstitial lung diseases);
  • - Expected cardiovascular intervention within three months.
  • - Being currently enrolled in randomized controlled trials or trial with study medication
  • - Waiting for a heart or lung transplantation
  • - Receiving of renal dialysis
  • - Diabetes Mellitus type I
  • - HADS (Hospital Anxiety and Depression Scale)-score of * 11 for depression and/or anxiety

研究者

相似试验